AKT1 and colon carcinoma: In particular, these different InsPs may have different specific activities and benefits, as previously suggested to explain the effects of InsPs on rats with type 2 diabetes [25] and on the proliferation of colon carcinoma, in which InsP4 and InsP5 inhibit the activation of the AKT protein [26].